752
T. Kawabata et al.
PAPER
octyl 4-O-isobutyryl- and 3-O-isobutyryl-b-D-glucopyranoside
(88:12, 37.9 mg, 52%) and recovered starting material (5.6 mg,
10%). Identification of the regioisomeric products was unambigu-
ously made by comparison with pure regioisomers prepared inde-
pendently by a conventional protection–deprotection procedure.15
References
(1) (a) Kawabata, T.; Nagato, M.; Takasu, K.; Fuji, K. J. Am.
Chem. Soc. 1997, 119, 3169. (b) Kawabata, T.; Yamamoto,
K.; Momose, Y.; Nagaoka, Y.; Yoshida, H.; Fuji, K. Chem.
Commun. 2001, 2700.
The preparation and characterization of octyl 2-, 3-, 4- and 6-O-
isobutyryl-b-D-glucopyranosides has been previously described.15
Selected data for these are as follows.
(2) Chiral PPY and DMAP analogues have been developed for
enantioselective catalysis, see: (a) Vedejs, E.; Chen, X. J.
Am. Chem. Soc. 1996, 118, 1809. (b) Ruble, J. C.; Fu, G. C.
J. Org. Chem. 1996, 61, 7230. (c) Ruble, J. C.; Latham, H.
A.; Fu, G. C. J. Am. Chem. Soc. 1997, 119, 1492.
(d) Ruble, J. C.; Fu, G. C. J. Am. Chem. Soc. 1998, 120,
11532. (e) Liang, J.; Ruble, J. C.; Fu, G. C. J. Org. Chem.
1998, 63, 3154. (f) Tao, B.; Ruble, J. C.; Hoic, D. A.; Fu, G.
C. J. Am. Chem. Soc. 1999, 121, 10452. (g) Ie, Y.; Fu, G. C.
Chem. Commun. 2000, 119. (h) Spivey, A. C.; Fekner, T.;
Spey, S. E. J. Org. Chem. 2000, 65, 3154. (i) Spivey, A. C.;
Maddaford, A.; Fekner, T.; Redgrave, A. J.; Frampton, C. S.
J. Chem. Soc., Perkin Trans. 1 2000, 3460. (j) Naraku, G.;
Shimomoto, N.; Hanamoto, T.; Inanaga, J. Enantiomer
2000, 5, 135. (k) Arai, S.; Bellemin-Laponnaz, S.; Fu, G. C.
Angew. Chem. Int. Ed. 2001, 40, 647. (l) Priem, G.; Anson,
M. S.; Macdonald, S. J. F.; Pelotier, B.; Campbell, I. B.
Tetrahedron Lett. 2002, 43, 6001. (m) Kim, K.-S.; Park, S.-
H.; Chang, H.-J.; Kim, K. S. Chem. Lett. 2002, 1114.
(n) Shaw, S. A.; Aleman, P.; Vedejs, E. J. Am. Chem. Soc.
2003, 125, 13368. (o) Spivey, A. C.; Zhu, F.; Mitchell, M.
B.; Davey, S. G.; Jarvest, R. L. J. Org. Chem. 2003, 68,
7379. (p) Tabanella, S.; Valanocogne, I.; Jackson, R. F. W.
Org. Biomol. Chem. 2003, 1, 4254. (q) Priem, G.; Pelotier,
B.; Macdonald, S. J. F.; Anson, M. S.; Campbell, I. B.
J. Org. Chem. 2003, 68, 3844. (r) Pelotier, B.; Priem, G.;
Campbell, I. B.; Macdonald, S. J. F.; Anson, M. S. Synlett
2003, 679. (s) Spivey, A. C.; Leese, D. P.; Zhu, F.; Davey,
S. G.; Jarvest, R. L. Tetrahedron 2004, 60, 4513. (t) Arp, F.
O.; Fu, G. C. J. Am. Chem. Soc. 2006, 128, 14264.
(3) Kawabata, T.; Stragies, R.; Fukaya, T.; Fuji, K. Chirality
2003, 15, 71.
Octyl 2-O-Isobutyryl-b-D-glucopyranosides
1H NMR (400 MHz, CDCl3): d = 4.74 (dd, J = 9.3, 8.0 Hz, 1 H),
4.43 (d, J = 8.0 Hz, 1 H), 4.34 (br s, 1 H), 3.99 (br s, 1/2H), 3.90–
3.80 (m, 2 H), 3.50 (dt, J = 9.7, 6.5 Hz, 1 H), 3.67 (br t, J = 9.2 Hz,
1 H), 3.59 (br t, J = 9.4 Hz, 1 H), 3.43 (dt, J = 9.7, 6.9 Hz, 1 H), 3.33
(dt, J = 9.2, 3.4 Hz, 1 H), 3.19 (br s, 1/2H), 2.60 (hept, J = 7.0 Hz,
1 H), 2.25 (br s, 1 H), 1.60–1.50 (m, 2 H), 1.30–1.22 (m, 10 H),
1.18 (d, J = 7.0 Hz, 6 H), 0.88 (t, J = 6.8 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 177.09, 100.98, 77.23, 75.38,
73.73, 70.49, 70.18, 61.76, 34.09, 31.83, 29.56, 29.38, 29.24, 25.93,
22.65, 19.04, 18.81, 14.08.
Octyl 3-O-Isobutyryl-b-D-glucopyranosides
1H NMR (400 MHz, CDCl3): d = 4.90 (t, J = 9.3 Hz, 1 H), 4.37 (d,
J = 7.8 Hz, 1 H), 3.94–3.80 (m, 2 H), 3.90 (dt, J = 9.4, 6.8 Hz, 1 H),
3.67 (br t, J = 9.3 Hz, 1 H), 3.56 (dt, J = 9.4, 6.8 Hz, 1 H), 3.49 (br
t, J = 8.7 Hz, 1 H) 3.42 (ddd, J = 9.7, 4.6, 3.6 Hz, 1 H) 3.12 (br s,
1 H), 2.67 (hept, J = 7.0 Hz, 1 H), 2.52 (br s, 1 H), 1.81 (br s, 1 H),
1.65–1.59 (m, 2 H), 1.38–1.18 (m, 10 H), 1.22 (d, J = 7.0 Hz, 3 H),
1.21 (d, J = 7.0 Hz, 3 H), 0.88 (t, J = 6.9 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 178.96, 102.81, 78.03, 75.72,
72.20, 70.53, 69.79, 62.34, 34.15, 31.80, 29.61, 29.36, 29.22, 25.93,
22.64, 18.95, 18.92, 14.09.
Octyl 4-O-Isobutyryl-b-D-glucopyranosides
1H NMR (400 MHz, CDCl3): d = 4.85 (t, J = 9.7 Hz, 1 H), 4.32 (d,
J = 7.8 Hz, 1 H), 3.89 (dt, J = 9.4, 7.0 Hz, 1 H), 3.69 (t, J = 8.8 Hz,
2 H), 3.53 (dt, J = 9.4, 7.0 Hz, 1 H), 3.48–3.40 (m, 3 H), 2.65 (br s,
1 H), 2.62 (hept, J = 7.0 Hz, 1 H), 1.63 (quin, 7.0 Hz, 2 H), 1.40–
1.20 (m, 10 H), 1.19 (d, J = 7.0 Hz, 3 H), 1.19 (d, J = 7.0 Hz, 3 H),
0.88 (t, J = 6.9 Hz, 3 H).
(4) Kawabata, T.; Stragies, R.; Fukuya, T.; Nagaoka, Y.;
Schedel, H.; Fuji, K. Tetrahedron Lett. 2003, 44, 1545.
(5) The structure of the acylpyridinium ion is drawn as 8 with
the iminium +N=C substructure because of the reported
structure of several N-acyl-4-dialkylaminopydinium ions,
see: (a) Jones, P. G.; Linoh, K.; Blaschette, A.
13C NMR (100 MHz, CDCl3): d = 177.52, 102.59, 74.41, 74.23,
74.16, 70.60, 70.42, 61.46, 34.05, 31.83, 29.60, 29.41, 29.26, 25.93,
22.66, 19.00, 18.85, 14.10.
Z. Naturforsch. 1990, 45b, 267. (b) Lohse, C.; Hollenstein,
S.; Laube, T. Angew.Chem. Int. Ed. Engl. 1991, 30, 1656.
(c) Hollenstein, S.; Lohse, C.; Laube, T. Croat. Chem. Acta
1992, 65, 727. (d) Tao, B.; Ruble, J. C.; Hoic, D. A.; Fu, G.
C. J. Am.Chem. Soc. 1999, 121, 5091.
Octyl 6-O-Isobutyryl-b-D-glucopyranosides
1H NMR (400 MHz, CDCl3): d = 4.61 (br s, 1 H), 4.37 (dd, J = 12.1,
2.5 Hz, 1 H), 4.32 (dd, J = 12.1, 5.8 Hz, 1 H), 4.26 (d, J = 7.8 Hz,
1 H), 4.19 (m, 1 H), 3.84 (dt, J = 9.4, 7.0 Hz, 1 H), 3.76 (br s, 1 H),
3.57–3.48 (m, 1 H), 3.51 (dt, J = 9.4, 7.3 Hz, 1 H), 3.46 (dd, J = 5.8,
2.7 Hz, 1 H), 3.36 (t, J = 8.7 Hz, 2 H), 2.60 (hept, J = 7.0 Hz, 1 H),
1.64–1.58 (m, 2 H), 1.29–1.26 (m, 10 H), 1.18 (d, J = 7.0 Hz, 3 H),
1.17 (d, J = 7.0 Hz, 3 H), 0.88 (t, J = 6.8 Hz, 3 H).
(6) Trzeciak, A.; Bannwarth, W. Synthesis 1996, 1433.
(7) Wagaw, S.; Buchwald, S. L. J. Org. Chem. 1996, 61, 7240.
(8) Regioselective protection of glucose derivatives has been
reported, see: Wang, C.-C.; Lee, J.-C.; Luo, S.-Y.; Kulkarni,
S. S.; Huang, Y.-W.; Lee, C.-C.; Chang, K.-L.; Hung, S.-C.
Nature 2007, 446, 896.
(9) Site-selective acylation of erythromycin has been
developed, see: Lewis, C. A.; Miller, S. J. Angew. Chem. Int.
Ed. 2006, 45, 5616.
13C NMR (100 MHz, CDCl3): d = 177.69, 102.59, 76.16, 73.89,
73.53, 70.37, 70.31, 63.52, 33.95, 31.84, 29.62, 29.41, 29.28,
25.92, 22.65, 19.03, 18.95, 14.09.
(10) (a) Therisod, M.; Klibanov, A. M. J. Am. Chem. Soc. 1987,
109, 3977. (b) Björkling, F.; Godtfredsen, S. E.; Kirk, O. J.
Chem. Soc., Chem. Commun. 1989, 934.
(11) Kattnig, E.; Albert, M. Org. Lett. 2004, 6, 945.
(12) We recently reported regioselective acylation of 6-O-
protected octyl b-D-glucopyranosides by DMAP catalysis,
see: Muramatsu, W.; Kawabata, T. Tetrahedron Lett. 2007,
48, 5031.
Acknowledgment
This work was supported by a Grant-in-Aid for Scientific Research
(A) from the Ministry of Education, Culture, Sports, Science and
Technology, Japan.
Synthesis 2008, No. 5, 747–753 © Thieme Stuttgart · New York